Omalizumab inhibits FcεRI-mediated activation of human mast cells by removing surface IgE

DOIResolve DOI: http://doi.org/10.1016/j.jaci.2009.12.712
AuthorSearch for: ; Search for:
TypeArticle
Proceedings titleJournal of allergy and clinical immunology
Conference2010 American Academy of Allergy, Asthma and Immunology Annual Meeting (AAAAI Annual Meeting), Feb. 2010, New Orleans, Louisianna, USA, Feb. 2010, New Orleans, Louisianna, USA
Volume125
Issue2 (Suppl. 1)
Publication date
LanguageEnglish
AffiliationNRC Institute for Nutrisciences and Health; National Research Council Canada
Peer reviewedNo
NPARC number17364186
Export citationExport as RIS
Report a correctionReport a correction
Record identifiera96a8773-2cb0-401f-962e-a4198f2bb19b
Record created2012-02-18
Record modified2016-05-09
Bookmark and share
  • Share this page with Facebook (Opens in a new window)
  • Share this page with Twitter (Opens in a new window)
  • Share this page with Google+ (Opens in a new window)
  • Share this page with Delicious (Opens in a new window)